ELI LILLY & Co is 27.4x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($1.072 T vs $39.12 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TEVA | LLY |
|---|---|---|
| Market cap | $39.12 B | $1.072 T |
| US-listed rank | #392 | #10 |
| Revenue (latest FY) | $17.26B | $65.18B |
| Net income (latest FY) | $1.41B | $20.64B |
| Net margin | 8.2% | 31.7% |
| P/E (trailing FY) | 27.7 | 51.9 |
| SEC filings | 2,473 | 989 |
ELI LILLY & Co is 27.4x more valuable than TEVA PHARMACEUTICAL INDUSTRIES LTD by market capitalization ($1.072 T vs $39.12 B).
In their latest fiscal years, TEVA PHARMACEUTICAL INDUSTRIES LTD reported $17.26B in revenue while ELI LILLY & Co reported $65.18B.
Full pages: TEVA PHARMACEUTICAL INDUSTRIES LTD and ELI LILLY & Co, or browse the full rankings.